Minireviews
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 16, 2023; 11(17): 3949-3957
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.3949
Prediction models for recurrence in patients with small bowel bleeding
Ji Hyun Kim, Seung-Joo Nam
Ji Hyun Kim, Seung-Joo Nam, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon 24341, South Korea
Author contributions: Kim JH and Nam SJ wrote the manuscript; and Nam SJ supervised the reported work.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Seung-Joo Nam, MD, PhD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangwon National University Hospital, Baengnyeong-ro 156, Chuncheon, Gangwon-Do, 24289, South Korea. pinetrees@daum.net
Received: December 27, 2022
Peer-review started: December 27, 2022
First decision: March 20, 2023
Revised: April 10, 2023
Accepted: May 15, 2023
Article in press: May 15, 2023
Published online: June 16, 2023
Processing time: 166 Days and 18.4 Hours
Abstract

Obscure gastrointestinal bleeding (OGIB) has traditionally been defined as gastrointestinal bleeding whose source remains unidentified after bidirectional endoscopy. OGIB can present as overt bleeding or occult bleeding, and small bowel lesions are the most common causes. The small bowel can be evaluated using capsule endoscopy, device-assisted enteroscopy, computed tomography enterography, or magnetic resonance enterography. Once the cause of small-bowel bleeding is identified and targeted therapeutic intervention is completed, the patient can be managed with routine visits. However, diagnostic tests may produce negative results, and some patients with small bowel bleeding, regardless of diagnostic findings, may experience rebleeding. Predicting those at risk of rebleeding can help clinicians form individualized surveillance plans. Several studies have identified different factors associated with rebleeding, and a limited number of studies have attempted to create prediction models for recurrence. This article describes prediction models developed so far for identifying patients with OGIB who are at greater risk of rebleeding. These models may aid clinicians in forming tailored patient management and surveillance.

Keywords: Obscure gastrointestinal bleeding; Prediction model; Rebleeding; Small bowel bleeding; Video capsule endoscopy

Core Tip: Some patients with small bowel bleeding, regardless of the diagnostic findings, may experience rebleeding. Predicting those at risk of rebleeding can help clinicians form individualized surveillance plans. This article describes prediction models developed so far for identifying patients with obscure gastrointestinal bleeding who are at greater risk of rebleeding. There are prediction models that can help identify patients with a greater risk of rebleeding.